Indeed, LPS-treated PBMCs expressed significantly higher levels of ZC3H12A and RC3H1 compared to untreated PBMCs from LN patients (p = 0.041) (Figure 3A,D), though, the IL-6 level was significantly higher (p = 0.041) (Figure 3E). This evidence concerns the gene ZC3H12A and lobular neoplasia.